RSS
Логотип
Баннер в шапке 1
Баннер в шапке 2

Medplant: Device for starting the heart during resuscitation

Product
Developers: Medplant
Date of the premiere of the system: September 2023
Branches: Pharmaceuticals, Medicine, Healthcare

2023: Product Announcement

In mid-September 2023, it became known that Moscow scientists developed an automatic device for launching the heart during resuscitation. The device has no analogues in Russia.

The mayor spoke about the project. Moscow Sergei Sobyanin The system performs indirect heart massage, freeing doctors of their hands to carry out other manipulations when saving people. Experts believe that the development will increase the percentage of patient survival and improve the quality of medical care.

Automatic device for starting the heart during resuscitation
File:Aquote1.png
The device has no analogues in Russia and has a number of advantages over foreign systems. For example, it is lighter, because it is made of modern materials, and more convenient to use due to work on two batteries, - notes Sobyanin.
File:Aquote2.png

It is said that it takes only about 20 seconds to install the system and prepare it for operation. The device can be used in ambulances and medical institutions. The developers also intend to connect the system to a ventilator. This will create a unique resuscitation complex.

At the same time, the Center for Cardioangiology of Sechenov University reported on the introduction of a modern minimally invasive method of treating arrhythmia. We are talking about cryogenic isolation of the mouths of pulmonary veins. During the procedure, with the help of special balloon catheters, cold action is carried out on the tissue of the pulmonary veins. For this operation, a special set of high-tech equipment is used: the latest generation cryoconsol, a cryoballon catheter, a delivery device and a set of connecting cables. The cooling agent is liquid nitrous oxide, which allows you to create a temperature in the exposure area up to minus 50 degrees Celsius. The catheter is inserted into the patient through the femoral vein in the upper third of the thigh and by means of a delivery device and a set of connecting cables "follows" to the pulmonary veins. When exposed to low temperatures, cold denaturation of the protein occurs in the tissues and they stop conducting electrical stimuli. Thus, a barrier is created - isolation for the penetration into the heart of pathological electrical impulses from areas of increased excitation located in the pulmonary veins during atrial fibrillation.[1]

Notes